Resources
About Us
Africa IVD Market Size & Forecast The Africa IVD market was valued at $1.33 billion in 2024. This market is expected to reach $1.70 billion by 2032 from an estimated $1.37 billion in 2025, at a CAGR of 3.1% during the forecast period of 2025–2032. The Africa IVD market expenditure and the rising prevalence ...
The Kenya IVD Market was valued at $53.43 million in 2024. This market is expected to reach $68.66 million by 2032 from an estimated $55.23 million in 2025, at a CAGR of 3.2% during the forecast period of 2025-2032. Kenya IVD Market Size & Forecast The growth of the Kenya IVD market is driven by high ...
The Côte d’Ivoire IVD Market was valued at $21.0 million in 2024. This market is expected to reach $25.8 million by 2032 from an estimated $21.5 million in 2025, at a CAGR of 2.6% during the forecast period of 2025-2032. Côte d’Ivoire IVD Market Size & Forecast The growth of the Côte d’Ivoire ...
The Asia-Pacific DTC Laboratory Testing Market is projected to reach $1.58 billion by 2032, at a CAGR of 12.8% from 2025 to 2032. Direct-to-consumer or DTC tests are the ones that are self-ordered by consumers without the involvement of their healthcare providers. The sample that is collected from the ...
The Digital Pathology Market is poised to reach $1.86 billion by 2032, exhibiting a CAGR of 8.7% from 2025 to 2032. Digital pathology entails the interpretation and management of pathology information derived from digitized glass slides. It has become a mainstream choice for routine diagnostics and ...
The North America Tissue Diagnostics Market is expected to reach $2.96 billion by 2032, at a CAGR of 7% during the forecast period 2025–2032. Tissue diagnostics involves the study of tissue to diagnose disease and determine the type of the tissue, whether it's cancerous, and the characteristics ...
The Blood Glucose Monitoring Devices Market is expected to reach $21.71 billion by 2032 at a CAGR of 7.5% from 2025 to 2032. Blood glucose monitoring devices are used for managing diabetes and monitoring the blood glucose levels of diabetic patients. These devices allow patients to monitor their blood ...
The Europe IVD Market is expected to reach $39.77 billion by 2032 at a CAGR of 3.7% from 2025 to 2032. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range of diseases. IVD tests are used to screen ...
Europe Point-of-Care Diagnostics Market is expected to reach $12.98 billion by 2032, at a CAGR of 4.1% during the forecast period 2025–2032. Point-of-care diagnostics, or bedside tests, are diagnostic tests performed on-site by healthcare professionals. These tests provide quick and accurate results ...
The South East Asia IVD Market is expected to record a CAGR of 7% from 2025 to 2032, reaching $4.11 billion by 2032. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range of diseases. IVD tests screen ...
The Europe DTC Laboratory Testing Market is projected to reach $1.59 billion by 2032, at a CAGR of 10.8% from 2025 to 2032. Direct-to-consumer, DTC tests, or at-home genetic tests, are medical or genetic tests that consumers can order and perform at home without the involvement of a healthcare professional. ...
The North America Molecular Diagnostics Market is expected to reach $18.13 billion by 2032 at a CAGR of 5.3% from 2025 to 2032. Molecular diagnostics help detect the targeted genetic material in human, viral, and bacterial genomes. Molecular diagnostic tests are increasingly being used in many areas, ...
The Asia-Pacific Point-of-Care Diagnostics Market is projected to reach $11.80 billion by 2032, at a CAGR of 7.5% from 2025 to 2032. Point-of-Care diagnostics (PoC diagnostics), also known as bedside or near-patient testing, refers to medical diagnostic testing conducted near the patient, typically at ...
The Europe Molecular Diagnostics Market is projected to reach $13.25 billion by 2032, at a CAGR of 4% from 2025 to 2032. Molecular diagnostics is a branch of medical and clinical laboratory science that involves the detection, identification, and measurement of specific genetic or molecular markers within ...
The Asia-Pacific Molecular Diagnostics Market is projected to reach $11.87 billion by 2032, at a CAGR of 7.2% from 2025 to 2032. Molecular diagnostics help detect the targeted genetic material in human, viral, and bacterial genomes. Molecular diagnostic tests are increasingly used in many areas, including ...
The U.S. Point-of-Care Diagnostics Market is expected to reach $13.16 billion by 2032, at a CAGR of 4.3% during the forecast period 2025–2032. Point-of-care diagnostics, or bedside tests, are diagnostic tests performed on-site by healthcare professionals. These tests provide quick and accurate results ...
The Asia-Pacific IVD Market was valued at $21.09 billion in 2024. This market is expected to reach $36.02 billion by 2032, from an estimated $22.44 billion in 2025, at a CAGR of 7% during the forecast period 2025-2032. In vitro diagnostics (IVD) is focused on analyzing urine, blood, and other ...
The Latin America Molecular Diagnostics Market was valued at $1.55 billion in 2024. This market is expected to reach $2.5 billion by 2032, from an estimated $1.64 billion in 2025, at a CAGR of 6.3% during the forecast period 2025-2032. Molecular diagnostics help detect the targeted genetic material ...
The South East Asia Molecular Diagnostics Market was valued at $492.29 million in 2023. This market is expected to reach $891.87 million by 2031, from an estimated $527.19 million in 2024, at a CAGR of 7.8% during the forecast period 2024-2031. South East Asia Molecular Diagnostics Market Size & Forecast Molecular ...